Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stocks, par value $0,0001 per share
-
Shares outstanding
-
58.5M
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
23.5M
-
Shares change
-
-1.94M
-
Total reported value, excl. options
-
$66.9M
-
Value change
-
-$8.83M
-
Put/Call ratio
-
1.24
-
Number of buys
-
35
-
Number of sells
-
-63
-
Price
-
$2.85
Significant Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) as of Q2 2022
106 filings reported holding BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share as of Q2 2022.
BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.5M shares
of 58.5M outstanding shares and own 40.15% of the company stock.
Largest 10 shareholders include TANG CAPITAL MANAGEMENT LLC (3.37M shares), Soleus Capital Management, L.P. (3.26M shares), JANUS HENDERSON GROUP PLC (2.34M shares), Cormorant Asset Management, LP (2.04M shares), VANGUARD GROUP INC (1.14M shares), MORGAN STANLEY (1.08M shares), RA CAPITAL MANAGEMENT, L.P. (1.03M shares), BAKER BROS. ADVISORS LP (825K shares), RENAISSANCE TECHNOLOGIES LLC (780K shares), and BlackRock Inc. (688K shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.